We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Recipharm and Adroit Science Form Collaboration
News

Recipharm and Adroit Science Form Collaboration

Recipharm and Adroit Science Form Collaboration
News

Recipharm and Adroit Science Form Collaboration

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Recipharm and Adroit Science Form Collaboration"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Recipharm AB and Adroit Science AB have announced the formation of a new strategic collaboration. Adroit Science AB will support Recipharm’s pharmaceutical development with high quality solid state characterization services.

By combining expertise in formulation development, API development, chemical analysis and solid state characterization, both the speed and cost of development can be reduced whilst, at the same time, quality is improved.

“I am very excited about this collaboration”, says Carl-Johan Spak, Executive Vice President, Development & Technology at Recipharm. “With the addition of development services from Adroit, we will have a very competitive offering, which will help our customers to progress their projects in a highly efficient way. Adroit Science AB has fast established itself as one of the leading providers of solid state characterization services in Northern Europe. Indeed, we can offer an even better service to our customers through this collaboration, including complete development from molecule to product.”

“Adroit Science and Recipharm have already cooperated in a number of successful projects, and this formal partnership marks the logical next step in the mutual development of our strategic relationship. We are delighted to join forces with a leading CDMO like Recipharm and predict that this will bring new opportunities in worldwide customer support” remarked Hans Gredeby, CEO of Adroit Science AB.

Advertisement